Related Experiment Videos
[Massive skeletal fluorosis in compromised kidney function].
Summary
This case report highlights skeletal fluorosis in an elderly man due to chronic fluoride exposure exacerbated by kidney insufficiency. It emphasizes monitoring renal function during fluoride therapy.
Area of Science:
- Nephrology
- Endocrinology
- Skeletal Diseases
Background:
- Chronic kidney disease (CKD) can impair fluoride excretion, increasing the risk of toxicity.
- Arteriosclerosis is a common comorbidity in the elderly, often leading to renal insufficiency.
- Fluoride has therapeutic uses but requires careful dosage, especially in patients with compromised renal function.
Observation:
- An 86-year-old male patient presented with severe skeletal fluorosis.
- The patient had a history of arteriosclerosis leading to renal insufficiency.
- The skeletal fluorosis developed secondary to chronic fluoride exposure.
Findings:
- Massive skeletal fluorosis was diagnosed in the patient.
- Renal insufficiency was identified as the primary factor enabling fluoride accumulation.
- Chronic exposure to fluorides, even at levels not typically considered toxic, led to severe disease in this context.
Implications:
- This case underscores the critical need to assess renal functional parameters before and during fluoride therapy.
- Understanding the interplay between renal function and fluoride metabolism is crucial for preventing iatrogenic fluorosis.
- Clinicians should exercise caution when prescribing fluoride-containing medications or treatments to elderly patients with or at risk for renal impairment.